Prospective, Cross-sectional and Multicenter Study, Evaluating the Diagnosis Accuracy of the Controlled Attenuation Parameter(CAP) Measured by FibroScan® (Either With M+ or XL+ Probe) in Patient With Non-Alcoholic Fatty Liver Disease Using Liver Biopsy as Reference.

NCT01985009 · clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
450
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Echosens